Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial is a PHASE2 clinical asset sponsored by Dallas VA Medical Center in Amyotrophic Lateral Sclerosis (ALS). SEO and diligence focus: Antioxidants, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Amyotrophic Lateral Sclerosis (ALS)
Modality: combination therapy
Target: Antioxidants
Sponsor: Dallas VA Medical Center
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 24, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Antioxidants
View original source fields
Condition raw: Amyotrophic Lateral Sclerosis (ALS)
Condition normalized: Amyotrophic Lateral Sclerosis (ALS)
Modality raw: combination therapy
Modality normalized: combination therapy
Target raw: Antioxidants
Target normalized: Antioxidants